Challenges of longevity in developed countries: Vascular prevention of dementia as an immediate clue to tackle an upcoming medical, social and economic stretch

Neurodegenerative Diseases

Volumn 8, Issue 5, 2011, Pages 275-282

  Wehling, Martin ^a   Groth, Hans ^b,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ST GALLEN   (Switzerland)

^c Pfizer Switzerland   (Switzerland)

Author keywords

80+ generation; Aging societies; Dementia; Socioeconomic burden; Translational research; Vascular prevention

Indexed keywords

AMYLOID BETA PROTEIN; DONEPEZIL; GALANTAMINE; MEMANTINE; RIVASTIGMINE; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; CHINA; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 21; CONTROLLED CLINICAL TRIAL (TOPIC); DEMENTIA; DEVELOPED COUNTRY; DRUG APPROVAL; DRUG EFFICACY; EFFECT SIZE; FRANCE; GENE MUTATION; GERMANY; HEALTH CARE COST; HUMAN; HYPERTENSION; INDIA; ITALY; JAPAN; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LONGEVITY; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUALITY OF LIFE; REVIEW; SOCIOECONOMICS; SPAIN; SWEDEN; SWITZERLAND; UNITED STATES;

AGING; DEMENTIA; DEVELOPED COUNTRIES; HUMANS; LIFE EXPECTANCY; LONGEVITY; RISK FACTORS; SOCIOECONOMIC FACTORS; VASCULAR DISEASES;

EID: 79958829958     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000322791     Document Type: Review

References (38)

1. UN Population Division's 'World Population Prospects' Database Link. http://esa.un.org/unpp/ (accessed August 4, 2010).
2. Pötzsch O: Geburten in Deutschland. Statistisches Bundesamt: 2007. http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/ DE/Content/Publikationen/Fachveroeffentlichungen/Bevoelkerung/ BroschuereGeburtenDeutschland,property=file.pdf (accessed August 4, 2010).
3. Christensen K, Doblhammer G, Rau R, Vaupel JW: Ageing populations: the challenges ahead. Lancet 2009;374:1196-1208.
4. Maier H, Scholz R: Immer mehr Menschen können 105. Geburtstag feiern (in German). Demogr Forsch 2004;1:4.
5. Van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA: Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998;51:367-375. (Pubitemid 28223302)
6. Beske F, Katalinic A, Peters E, Pritzkuleit R: Morbiditätsprognose 2050. Ausgewählte Krankheiten für Deutschland, Brandenburg und Schleswig-Holstein (in German). Kiel, Schmidt & Klaunig 2009, p 114.
7. Alzheimerinfo. 2009. http://www.alzheimerinfo.de/alzheimer/zahlen/ (accessed August 4, 2010).
8. Staehelin HB: Epidemiologie der Demenzerkrankungen (in German). Schweiz Med Forum 2004;4:247-250.
9. Schweizerische Alzheimervereinigung: 102,000 Menschen mit Demenz in der Schweiz. 2009. http://www.alz.ch/d/pdf/schweiz-2008-d.pdf (accessed August 3, 2010).
10. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimer's Disease International: Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117. (Pubitemid 41797645)
11. Shoji M: Clinical approach and pathological cascade of dementia (in Japanese). Rinsho Shinkeigaku 2008;48:467-475.
12. Alzheimer's Association: 2009 Alzheimer's disease facts and figures. Alzheimers Dement 2009;5:234-270.
13. UN Millennium Development Goals Report. 2009. http://www.un.org/ millenniumgoals/pdf/MDG-Report-2009-ENG.pdf (accessed August 3, 2010).
14. Bartus RT, Dean RL 3rd, Beer B, Lippa AS: The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-414.
15. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR: Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-1239. (Pubitemid 12106486)
16. Guan ZZ, Zhang X, Ravid R, Nordberg A: Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 2000;74:237-243. (Pubitemid 30012774)
17. Rogers SL, Doody RS, Pratt RD, Ieni JR: Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol 2000;10:195-203. (Pubitemid 30227620)
18. Farlow M, Anand R, Messina J Jr, Hartman R, Veach J: A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. Eur Neurol 2000;44:236-241.
19. Raskind MA, Peskind ER, Wessel T, Yuan W: Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology 2000;54:2261-2268. (Pubitemid 30416276)
20. Alzheimer's Association: Federal funding for Alzheimer research. 2009. http://www.alz.org/publicpolicyforum/08/downloads/Federal-Funding-Alz-Research. doc (accessed November 25, 2009).
21. Williamson J, Goldman J, Marder KS: Genetic aspects of Alzheimer disease. Neurologist 2009;15:80-86.
22. Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, Mandelkow E: Development of tau aggregation inhibitors for Alzheimer's disease. Angew Chem Int Ed Engl 2009;48:1740-1752.
23. Rafii MS, Aisen PS: Recent developments in Alzheimer's disease therapeutics. BMC Med 2009;7:7.
24. Clinicaltrials.gov.www.clinicaltrials.gov (accessed August 4, 2010).
25. Snowdon DA: Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 1997;37:150-156.
26. Curtis R, Geesamen BJ, DiStefano PS: Ageing and metabolism: drug opportunities. Nat Rev Drug Discov 2005;4:69-80.
27. Hennerici MG: What are the mechanisms for post-stroke dementia? Lancet Neurol 2009;8:973-975.
28. Viswanathan A, Rocca WA, Tzourio C: Vascular risk factors and dementia: how to move forward? Neurology 2009;72:368-374.
29. Yang DW, Kim BS, Park JK, Kim SY, Kim EN, Sohn HS: Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: adaptation of statistical parametric mapping. J Neurol Sci 2002;203-204:199-205.
30. Korczyn AD: Mixed dementia - The most common cause of dementia. Ann NY Acad Sci 2002;977:129-134.
31. Qiu CX, Winblad B, Fratiglioni L: The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4:487-499. (Pubitemid 40982459)
32. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ: Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000;21:49-55. (Pubitemid 30224785)
33. Nagai M, Hoshide S, Kario K: Hypertension and dementia. Am J Hypertens 2010;23:116-124.
34. McGuinness B, Todd S, Passmore P, Bullock R: Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009;2:CD004034.
35. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C, HYVET investigators: Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVETCOG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7:683-689.
36. Wittchen HU, Pieper L, Eichler T, et al: Prävalenz und Versorgung von Diabetes mellitus und Herz-Kreislauf-Erkrankungen: DETECT - eine bundesweite Versorgungsstudie an über 55.000 Hausarztpatienten; in Kirch W, Badura B, Pfaff H (eds): Prävention und Versorgungsforschung (in German). Heidelberg, Springer, 2007, pp 315-328.
37. Boersma E, Keil U, De Bacquer D, De Backer G, Pyörälä K, Poldermans D, Leprotti C, Pilotto L, de Swart E, Deckers JW, Heidrich J, Sans S, Kotseva K, Wood D, Ambrosio GB, EUROASPIRE I and II Study Groups: Blood pressure is insufficiently controlled in European patients with established coronary heart disease. J Hypertens 2003;21:1831-1840. (Pubitemid 37290101)
38. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952. (Pubitemid 39208455)